Switch to:
More From Other Websites
Tesaro Secures FDA Nod for Ovarian Cancer Drug Mar 28 2017
First Trump Hiccups, Now Brexit Flare-Ups Coming For Stocks Mar 27 2017
Tesaro Creeps Up On Rivals With Cancer Drug OK, But Merger Unlikely Mar 27 2017
AstraZeneca's Lung Cancer Drug Tagrisso Approved in China Mar 27 2017
AstraZeneca’s Lung Cancer Drug Secures China Approval (AZN) Mar 27 2017
5:48 am AstraZeneca: Tagrisso approved in China as first-in-class treatment for EGFR T790M... Mar 27 2017
Chinese drug approval boosts AstraZeneca's lung cancer hopes Mar 27 2017
Chinese drug approval boosts AstraZeneca's lung cancer hopes Mar 27 2017
Chinese drug approval boosts AstraZeneca's lung cancer hopes Mar 27 2017
Chinese drug approval boosts AstraZeneca's lung cancer hopes Mar 27 2017
AstraZeneca wins approval for lung cancer pill in China Mar 27 2017
New Lung Cancer Drug From AstraZeneca is Approved in China Mar 24 2017
AstraZeneca Stock Rising in '17: What's Working in its Favor? Mar 23 2017
Durvalumab and Tagrisso May Boost AstraZeneca’s Revenues in 2017 Mar 22 2017
How AstraZeneca Controlled Operating Expenses in 2016 Mar 22 2017
Novartis’ Heart Drug Fails Late Stage Trials (NVS, AZN) Mar 22 2017
What Will Drive AstraZeneca’s Oncology Revenues in 2017? Mar 22 2017
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017 Mar 21 2017
Why AstraZeneca’s Brilinta Could Become a Blockbuster Drug in 2017 Mar 21 2017
What to Expect from AstraZeneca’s Farxiga in 2017 Mar 21 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK